Literature DB >> 11326027

Evaluation of an automated liquid-handling system (Tecan Genesis RSP 100) in the Abbott LCx assay for Chlamydia trachomatis.

K L Hanson1, C P Cartwright.   

Abstract

The present study investigated the feasibility of automating the specimen-pipetting component of sample preparation in the LCx Chlamydia assay (LCx-CT assay; Abbott Laboratories, Chicago, Ill.) by using a commercially available liquid-handling system (Tecan Genesis RSP100; Tecan Inc., Research Triangle Park, N.C.). The Tecan instrument proved to be comparable in both precision and accuracy to a manual multipipettor (Eppendorf model 4850; Eppendorf Scientific, Westbury, N.Y.). The Tecan instrument was extensively checked for evidence of specimen-to-specimen transfer, and no level of contamination sufficient to generate a signal above the background in the LCx-CT assay was detected. Finally, pipetting speed was significantly improved by using the Tecan instrument. A mean time of 2.5 min was required to pipette a complete LCx-CT assay carousel (20 samples and 4 controls) with the Tecan instrument, whereas 8.4 min was required to pipette a comparable number of samples manually (P < 0.001).

Entities:  

Mesh:

Year:  2001        PMID: 11326027      PMCID: PMC88062          DOI: 10.1128/JCM.39.5.1975-1977.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Reproducibility problems with the Abbott laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  A M Gronowski; S Copper; D Baorto; P R Murray
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Adaptation of a T3-uptake test and of radioimmunoassays for serum digoxin, thyroxine, and triiodothyronine to an automated radioimmunoassay system--"Centria".

Authors:  G Ertingshausen; S I Shapiro; G Green; G Zborowski
Journal:  Clin Chem       Date:  1975-08       Impact factor: 8.327

3.  A partially automated radioligand binding assay system for use in clinical and pharmaceutical research.

Authors:  B Liebl; T Anhäupl; E Haen; B Günster; M Georgieff
Journal:  J Recept Res       Date:  1993

4.  Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix.

Authors:  J Schachter; W E Stamm; T C Quinn; W W Andrews; J D Burczak; H H Lee
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

Review 5.  Update on Chlamydia trachomatis.

Authors:  S Guaschino; F De Seta
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 6.  Evaluation and comparison of tests to diagnose Chlamydia trachomatis genital infections.

Authors:  D Taylor-Robinson
Journal:  Hum Reprod       Date:  1997-11       Impact factor: 6.918

7.  Performance of transcription-mediated amplification and ligase chain reaction assays for detection of chlamydial infection in urogenital samples obtained by invasive and noninvasive methods.

Authors:  A Stary; E Schuh; M Kerschbaumer; B Götz; H Lee
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 8.  DNA amplification assays: a new standard for diagnosis of Chlamydia trachomatis infections.

Authors:  T C Quinn
Journal:  Ann Acad Med Singapore       Date:  1995-07       Impact factor: 2.473

9.  Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine.

Authors:  H H Lee; M A Chernesky; J Schachter; J D Burczak; W W Andrews; S Muldoon; G Leckie; W E Stamm
Journal:  Lancet       Date:  1995-01-28       Impact factor: 79.321

  9 in total
  2 in total

1.  Chlamydia trachomatis diagnostics.

Authors:  M A Chernesky
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

2.  Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  R Marshall; M Chernesky; D Jang; E W Hook; C P Cartwright; B Howell-Adams; S Ho; J Welk; J Lai-Zhang; J Brashear; B Diedrich; K Otis; E Webb; J Robinson; H Yu
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.